• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Perspective: Appraisal of the Evidence Base to Update DRI Values-Lessons from the Past, Thoughts for the Future.观点:评估更新 DRIs 值的证据基础——从过去中吸取的教训,对未来的思考。
Adv Nutr. 2022 Aug 1;13(4):975-981. doi: 10.1093/advances/nmac041.
2
Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update).维生素 D 和钙:健康结果的系统评价(更新)。
Evid Rep Technol Assess (Full Rep). 2014 Sep(217):1-929. doi: 10.23970/AHRQEPCERTA217.
3
A report of activities related to the Dietary Reference Intakes from the Joint Canada-US Dietary Reference Intakes Working Group.一份与加拿大-美国联合膳食参考摄入量工作组相关的膳食参考摄入量活动报告。
Am J Clin Nutr. 2019 Feb 1;109(2):251-259. doi: 10.1093/ajcn/nqy293.
4
Vitamin D and calcium: a systematic review of health outcomes.维生素D与钙:健康结局的系统评价
Evid Rep Technol Assess (Full Rep). 2009 Aug(183):1-420.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Options for basing Dietary Reference Intakes (DRIs) on chronic disease endpoints: report from a joint US-/Canadian-sponsored working group.基于慢性病终点制定膳食参考摄入量(DRIs)的方法:美国/加拿大联合发起的工作组报告
Am J Clin Nutr. 2017 Jan;105(1):249S-285S. doi: 10.3945/ajcn.116.139097. Epub 2016 Dec 7.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Systematic review to support the development of nutrient reference intake values: challenges and solutions.系统评价支持营养素参考摄入量值的制定:挑战与解决方案。
Am J Clin Nutr. 2010 Aug;92(2):273-6. doi: 10.3945/ajcn.2009.29092. Epub 2010 May 26.
9
Dietary reference intakes for vitamin D: justification for a review of the 1997 values.维生素D的膳食参考摄入量:对1997年数值进行审查的理由。
Am J Clin Nutr. 2009 Mar;89(3):719-27. doi: 10.3945/ajcn.2008.26903. Epub 2009 Jan 28.
10
What is next for the Dietary Reference Intakes for bone metabolism related nutrients beyond calcium: phosphorus, magnesium, vitamin D, and fluoride?除钙之外,与骨代谢相关营养素(磷、镁、维生素D和氟)的膳食参考摄入量的下一步是什么?
Crit Rev Food Sci Nutr. 2009 Feb;49(2):136-44. doi: 10.1080/10408390701764468.

本文引用的文献

1
Artificial intelligence in nutrition research: perspectives on current and future applications.营养研究中的人工智能:当前与未来应用展望
Appl Physiol Nutr Metab. 2021 Sep 15:1-8. doi: 10.1139/apnm-2021-0448.
2
Obesity and Circulating Levels of Vitamin D before and after Weight Loss Induced by a Very Low-Calorie Ketogenic Diet.极低卡路里生酮饮食诱导减肥前后肥胖与循环维生素 D 水平。
Nutrients. 2021 May 27;13(6):1829. doi: 10.3390/nu13061829.
3
Vitamin D and Obesity: Current Evidence and Controversies.维生素 D 与肥胖:当前的证据和争议。
Curr Obes Rep. 2021 Jun;10(2):162-180. doi: 10.1007/s13679-021-00433-1. Epub 2021 Apr 1.
4
Perspective: Application of N-of-1 Methods in Personalized Nutrition Research.观点:在个性化营养研究中应用 N-of-1 方法。
Adv Nutr. 2021 Jun 1;12(3):579-589. doi: 10.1093/advances/nmaa173.
5
The possibilities of the use of N-of-1 and do-it-yourself trials in nutritional research.N-of-1 试验和自行开展试验在营养研究中的应用可能性。
PLoS One. 2020 May 6;15(5):e0232680. doi: 10.1371/journal.pone.0232680. eCollection 2020.
6
Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update).维生素 D 和钙:健康结果的系统评价(更新)。
Evid Rep Technol Assess (Full Rep). 2014 Sep(217):1-929. doi: 10.23970/AHRQEPCERTA217.
7
Defining Hypertension by Blood Pressure 130/80 mm Hg Leads to an Impressive Burden of Hypertension in Young and Middle-Aged Black Adults: Follow-Up in the CARDIA Study.将血压130/80 mmHg定义为高血压会导致年轻及中年黑人成年人中高血压负担显著:CARDIA研究的随访结果
J Am Heart Assoc. 2018 Jul 14;7(14):e009971. doi: 10.1161/JAHA.118.009971.
8
Vitamin D: Moving Forward to Address Emerging Science.维生素 D:为解决新兴科学问题而不断前进。
Nutrients. 2017 Dec 1;9(12):1308. doi: 10.3390/nu9121308.
9
Pathogenesis of age-related bone loss in humans.人类与年龄相关的骨丢失的发病机制。
J Gerontol A Biol Sci Med Sci. 2013 Oct;68(10):1226-35. doi: 10.1093/gerona/gls163. Epub 2012 Aug 24.
10
Vitamin D and calcium: a systematic review of health outcomes.维生素D与钙:健康结局的系统评价
Evid Rep Technol Assess (Full Rep). 2009 Aug(183):1-420.

观点:评估更新 DRIs 值的证据基础——从过去中吸取的教训,对未来的思考。

Perspective: Appraisal of the Evidence Base to Update DRI Values-Lessons from the Past, Thoughts for the Future.

机构信息

Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA, USA.

Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, USA.

出版信息

Adv Nutr. 2022 Aug 1;13(4):975-981. doi: 10.1093/advances/nmac041.

DOI:10.1093/advances/nmac041
PMID:35404437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9340966/
Abstract

Updating evidence-based nutrient guidance is challenging. One set of recommendations for which a robust evidence base is essential is the DRIs. In the past 10 y, DRI values for 4 essential nutrients have been re-evaluated in 2 groups: vitamin D and calcium, and sodium and potassium. To support the work of the committees tasked with evaluating the available evidence, the federal agencies that sponsor the DRI reviews contracted with the Agency for Healthcare Research and Quality to perform systematic reviews on predefined questions for these nutrient groups. Our aims were to tabulate the studies included in these systematic reviews and then, within the context of prespecified outcomes, summarize the totality of the available evidence and identify areas for consideration to maximize the value of the end products for future DRI committees. For the outcomes of interest, the available studies did not tend to report age data consistent with the current DRI categories. For some life stage categories, particularly pregnancy and lactation, there is a dearth of data. A wide range of study interventions were used, making it challenging to combine data to accurately derive or re-evaluate DRI values. There is also an under-representation of data on race/ethnicity and overweight/obesity, which is of concern, given the shifting demographic in the US and Canadian populations. Moving forward, it may be advantageous to develop a process to prospectively target research funding for studies designed to generate data that will most closely support re-evaluation of DRI values.

摘要

更新基于证据的营养指导是具有挑战性的。一组需要强有力的证据基础的建议是 DRIs。在过去的 10 年中,维生素 D 和钙以及钠和钾这 4 种必需营养素的 DRI 值已经在 2 个组中进行了重新评估。为了支持负责评估现有证据的委员会的工作,赞助 DRI 审查的联邦机构与医疗保健研究与质量署签订了合同,针对这些营养素组的预定义问题进行系统审查。我们的目的是列出这些系统评价中包含的研究,然后在预定结果的背景下,总结现有证据的总体情况,并确定需要考虑的领域,以最大限度地提高未来 DRI 委员会最终产品的价值。对于感兴趣的结果,现有研究并不倾向于报告与当前 DRI 类别一致的年龄数据。对于某些生命阶段类别,特别是妊娠和哺乳期,数据匮乏。使用了广泛的研究干预措施,这使得难以合并数据以准确得出或重新评估 DRI 值。关于种族/民族和超重/肥胖的数据也存在代表性不足,这令人担忧,因为美国和加拿大人口的人口结构正在发生变化。向前推进,可能有利于制定一个前瞻性的流程,为旨在生成最能支持 DRI 值重新评估的数据的研究提供研究资金。